Stem cell therapy for cardiac arrhythmias.

Area of Science:

• Cardiology
• Regenerative Medicine
• Biotechnology

Background:

• Stem cell transplantation (SCT) is being explored for cardiac conditions like myocardial infarction and heart failure.
• Concerns exist regarding potential arrhythmias post-SCT, though primarily linked to skeletal myoblast transplantation.
• Mechanisms for SCT-induced arrhythmias include electrotonic stimulation, electrical heterogeneity, nerve sprouting, and tissue injury.

Purpose of the Study:

• To review the potential of stem cell transplantation (SCT) in cardiac affections.
• To explore the development of biological cardiac pacemakers using cell and gene therapy.
• To address safety and efficacy concerns for clinical translation.

Main Methods:

• Review of clinical studies on SCT for cardiac conditions.
• Analysis of mechanisms potentially leading to arrhythmias after SCT.
• Examination of cell and gene therapy approaches for creating biological pacemakers in animal models.

Main Results:

• While SCT shows therapeutic potential, arrhythmias are a concern, particularly with skeletal myoblasts.
• Endothelial progenitor cells and bone marrow stem cells have not shown significant rhythm disturbances.
• Animal models demonstrate that gene and cell therapy can create biological pacemakers by modifying cardiomyocytes or using mesenchymal stem cells.

Conclusions:

• SCT holds promise for treating heart disease, but arrhythmia risk requires careful consideration.
• Biological pacemakers represent a novel therapeutic avenue, achievable through gene and cell-based strategies in preclinical studies.
• Further research is essential to resolve safety and efficacy issues before human clinical trials for biological pacemakers can commence.